Evaluation of the suppressing effect of Telmisarten on aneurysm development in hypertensive aortic aneurysm patients
Phase 4
- Conditions
- hypertensive aortic aneurysm patients
- Registration Number
- JPRN-UMIN000003377
- Lead Sponsor
- Tohoku university hospital cardiovascular surgery
- Brief Summary
The trial was canceled due to difficulties in registering for the trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
Taboo symptom of Telmisarten Pregnant women Liver and renal function failure Minority
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method